Loading…
Monday, June 25 • 12:45pm - 1:15pm
#128: PPD Innovation Theater: Reimagining Study Planning and Feasibility to Create More Efficient Clinical Trials

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session

Traditional study planning, driven by the number of sites estimated to achieve enrollment, is filled with inefficiencies and significant delays. Together with a key client, PPD’s Accelerated Enrollment Solutions business unit pioneered a new way to integrate the site network into study design to drastically reduces startup times and increases consistency/quality of data and study conduct. This new model is helping bring a lipid-lowering therapy with potential to change millions of lives to market in unprecedented timelines. This case study presentation highlights:

  • Shared sense of purpose and accountability across this program to deliver for the greater good and impact to global healthcare system
  • Change management on a global- and industry- scale to change the longstanding approach to study startup
  • Collaboration to generate evidence: unified to overcome obstacles and nimble to develop new approaches
  • The combination of patient data, modeling, direct marketing, predictive analytics to identify qualified patients and deliver enrollment volume and certainty

This unique approach illustrates how a sponsor and CRO can come together to change the face of drug development.

Chair

PPD, Inc.


Speakers
avatar for Tammy D’Lugin-Monroe

Tammy D’Lugin-Monroe

Exec. Dir. & Global Operations Lead, PPD
Tammy D’Lugin-Monroe is executive director and global operations lead for accelerated enrollment solutions with Acurian-PPD. She leads and directs the PatientAdvantage enrollment solution across all therapeutic areas, divisions and business units to ensure that those recruiting... Read More →
avatar for PPD, Inc.

PPD, Inc.

Pharmaceutical Product Development, Inc
avatar for Peter Wijngaard

Peter Wijngaard

Executive Vice President and Chief Development Officer, The Medicines Company
Peter is Executive Vice President and Chief Development Officer at The Medicines Company. Peter has extensive experience in the areas of global project leadership, business development, medical affairs, and pharmaceutical marketing. Previously, Peter led European Medical Affairs and... Read More →


Monday June 25, 2018 12:45pm - 1:15pm
Theater 2 Exhibit Hall Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA